Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Lancet (London, England)|September 26, 1987
Explanation for potency of repeated oral doses of morphine?G W Hanks, P J Hoskin, G W Aherne, et al.The Journal of Pharmacy and Pharmacology|April 1, 1989
Diamorphine stability in aqueous solution for subcutaneous infusionO A Omar, P J Hoskin, A Johnston, et al.Anaesthesia|July 1, 1985
Depression and anxiety in pain clinic patients. Rapid assessment by microcomputerG W Hanks, T Trueman, J W Lloyd, et al.British Journal of Clinical Pharmacology|April 1, 1989
The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteersP J Hoskin, G W Hanks, G W Aherne, et al.Clinical Orthopaedics and Related Research|March 1, 1997
Delayed local treatment of rabbit tibial fractures with biodegradable cefazolin microspheresE Jacob, G Cierny, K Zorn, et al.Infection and Immunity|March 11, 1991
Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growthM T Fallon, W H Benjamin, T R Schoeb, et al.British Journal of Anaesthesia|December 1, 1981
Controlled-release morphine tablets. A double-blind trial in dental surgery patientsG W Hanks, N M Rose, G W Aherne, et al.British Journal of Clinical Pharmacology|January 1, 1979
Single daily dose treatment of anxiety with clobazam or dipotassium clorazepateT D Wallis, J C Vallé-Jones, J R Craven, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|May 1, 1993
Evaluation of biodegradable cefazolin sodium microspheres for the prevention of infection in rabbits with experimental open tibial fractures stabilized with internal fixationE Jacob, G Cierny, M T Fallon, et al.Infection and Immunity|May 1, 1988
Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonisH L Watson, L S McDaniel, D K Blalock, et al.Pageof 7